These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27704358)

  • 1. A humanized chimeric antibody Hai178 targeted to the β subunit of F1F0 ATP synthase.
    Chen C; Liang H; Liao X; Pan J; Chen J; Zhao S; Xu Y; Wu Y; Ni J
    Tumour Biol; 2016 Oct; ():. PubMed ID: 27704358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual functions of a monoclonal antibody against cell surface F1F0 ATP synthase on both HUVEC and tumor cells.
    Zhang X; Gao F; Yu LL; Peng Y; Liu HH; Liu JY; Yin M; Ni J
    Acta Pharmacol Sin; 2008 Aug; 29(8):942-50. PubMed ID: 18664327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiostatin-like activity of a monoclonal antibody to the catalytic subunit of F1F0 ATP synthase.
    Chi SL; Wahl ML; Mowery YM; Shan S; Mukhopadhyay S; Hilderbrand SC; Kenan DJ; Lipes BD; Johnson CE; Marusich MF; Capaldi RA; Dewhirst MW; Pizzo SV
    Cancer Res; 2007 May; 67(10):4716-24. PubMed ID: 17510399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiostatin is directly cytotoxic to tumor cells at low extracellular pH: a mechanism dependent on cell surface-associated ATP synthase.
    Chi SL; Pizzo SV
    Cancer Res; 2006 Jan; 66(2):875-82. PubMed ID: 16424020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the ecto-beta subunit of F1F0-ATPase inhibits proliferation and induces apoptosis in acute myeloid leukemia cell lines.
    Wen-Li Z; Jian W; Yan-Fang T; Xing F; Yan-Hong L; Xue-Ming Z; Min Z; Jian N; Jian P
    J Exp Clin Cancer Res; 2012 Nov; 31(1):92. PubMed ID: 23140181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a novel inhibitory mAb against beta-subunit of F1F0 ATPase on HCC.
    Wang J; Han Y; Liang J; Cheng X; Yan L; Wang Y; Liu J; Luo G; Chen X; Zhao L; Zhou X; Wu K; Fan D
    Cancer Biol Ther; 2008 Nov; 7(11):1829-35. PubMed ID: 18836304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Inhibitor of the F1 subunit of ATP synthase (IF1) modulates the activity of angiostatin on the endothelial cell surface.
    Burwick NR; Wahl ML; Fang J; Zhong Z; Moser TL; Li B; Capaldi RA; Kenan DJ; Pizzo SV
    J Biol Chem; 2005 Jan; 280(3):1740-5. PubMed ID: 15528193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiostatin binds ATP synthase on the surface of human endothelial cells.
    Moser TL; Stack MS; Asplin I; Enghild JJ; Højrup P; Everitt L; Hubchak S; Schnaper HW; Pizzo SV
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2811-6. PubMed ID: 10077593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and therapeutic potency.
    Agadjanyan MG; Zagorski K; Petrushina I; Davtyan H; Kazarian K; Antonenko M; Davis J; Bon C; Blurton-Jones M; Cribbs DH; Ghochikyan A
    Mol Neurodegener; 2017 May; 12(1):33. PubMed ID: 28472993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preparation and identification of monoclonal antibody against human thrombomodulin.].
    Guo ZF; He SY; Zhu BY; Yan PK; Li BY; Liao DF
    Sheng Li Xue Bao; 2006 Aug; 58(4):391-6. PubMed ID: 16906342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a Novel Inhibitory Chimeric Anti-HER2 Monoclonal Antibody.
    Amiri MM; Bahadori T; Soltantoyeh T; Hosseini-Ghatar R; Golsaz-Shirazi F; Jeddi-Tehrani M; Shokri F
    Iran J Immunol; 2019 Mar; 16(1):26-42. PubMed ID: 30864553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ectopic localization of mitochondrial ATP synthase: a target for anti-angiogenesis intervention?
    Kenan DJ; Wahl ML
    J Bioenerg Biomembr; 2005 Dec; 37(6):461-5. PubMed ID: 16691484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of antibody-dependent cellular cytotoxicity of cetuximab by a chimeric protein encompassing interleukin-15.
    Ochoa MC; Minute L; López A; Pérez-Ruiz E; Gomar C; Vasquez M; Inoges S; Etxeberria I; Rodriguez I; Garasa S; Mayer JA; Wirtz P; Melero I; Berraondo P
    Oncoimmunology; 2018; 7(2):e1393597. PubMed ID: 29308327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The aleu207-->arg mutation in F1F0-ATP synthase from Escherichia coli. A model for human mitochondrial disease.
    Hartzog PE; Cain BD
    J Biol Chem; 1993 Jun; 268(17):12250-2. PubMed ID: 8509361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxic preconditioning-induced mitochondrial protection is not disrupted in a cell model of mtDNA T8993G mutation-induced F1F0-ATP synthase defect: the role of mitochondrial permeability transition.
    Huang WY; Jou MJ; Peng TI
    Free Radic Biol Med; 2014 Feb; 67():314-29. PubMed ID: 24291231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo anti-V-ATPase antibody treatment delays ovarian tumor growth by increasing antitumor immune responses.
    Kulshrestha A; Katara GK; Ibrahim SA; Riehl VE; Schneiderman S; Bilal M; Young AN; Levine S; Fleetwood S; Dolan J; Gilman-Sachs A; Beaman KD
    Mol Oncol; 2020 Oct; 14(10):2436-2454. PubMed ID: 32797726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of extracellular ATP on the cell-surface F1F0-ATP synthase-mediated intracellular triacylglycerol accumulation.
    Kita T; Arakaki N
    Biomed Res; 2015; 36(2):115-20. PubMed ID: 25876662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of subunit g of yeast mitochondrial F1F0-ATP synthase, a protein required for maximal activity of cytochrome c oxidase.
    Boyle GM; Roucou X; Nagley P; Devenish RJ; Prescott M
    Eur J Biochem; 1999 Jun; 262(2):315-23. PubMed ID: 10336613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of chLpMab-2, a human-mouse chimeric cancer-specific antihuman podoplanin antibody, via antibody-dependent cellular cytotoxicity.
    Kaneko MK; Yamada S; Nakamura T; Abe S; Nishioka Y; Kunita A; Fukayama M; Fujii Y; Ogasawara S; Kato Y
    Cancer Med; 2017 Apr; 6(4):768-777. PubMed ID: 28332312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric (mouse/human) anti-colon cancer antibody c30.6 inhibits the growth of human colorectal cancer xenografts in scid/scid mice.
    Mount PF; Sutton VR; Li W; Burgess J; McKEnzie IF; Pietersz GA; Trapani JA
    Cancer Res; 1994 Dec; 54(23):6160-6. PubMed ID: 7954462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.